MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 189 filers reported holding MYRIAD GENETICS INC in Q4 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,244,000 | -87.7% | 62,922 | -91.9% | 0.01% | -89.5% |
| Q3 2020 | $10,099,000 | +588.4% | 774,489 | +498.6% | 0.10% | +556.2% |
| Q2 2020 | $1,467,000 | -13.9% | 129,373 | +96.3% | 0.02% | -55.6% |
| Q2 2017 | $1,703,000 | -69.0% | 65,900 | -76.9% | 0.04% | -67.6% |
| Q1 2017 | $5,488,000 | +48.5% | 285,830 | +29.0% | 0.11% | +56.3% |
| Q4 2016 | $3,695,000 | -60.4% | 221,630 | -51.1% | 0.07% | -57.5% |
| Q3 2016 | $9,336,000 | – | 453,626 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
| Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
| Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
| PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
| EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
| Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
| AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
| Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
| Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |